% Expired Patents = 30.0

Forward Citations = 206

Loading Chart...

11 inventors (with patents filed for the assignee):

Byron C Robinson (10 out of 13 patents)

Avinash S Phadke (4 out of 4 patents)

Dipanjan Sengupta (3 out of 3 patents)

4. Barbara A Garcia (2 out of 2 patents)

5. G Patrick Stahly (1 out of 19 patents)

6. Steve Rychnovsky (1 out of 1 patent)

7. Stephanie Greene (1 out of 1 patent)

8. Ian M Leitch (1 out of 1 patent)

9. Alan R Morgan (1 out of 18 patents)

10. Hugh L Narciso, Jr (1 out of 24 patents)

11. Shwn-Ji Susie Lee (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 7521551 - Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy (2009-04-21),

2. 6906050 - Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis (2005-06-14),

3. 6827926 - Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy (2004-12-07),

4. 6794505 - Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy (2004-09-21),

5. 6605606 - Solid forms of tin ethyl etiopurpurin and processes for producing such forms (2003-08-12),

6. 6462192 - Processes for large scale production of tetrapyrroles (2002-10-08),

7. 6444194 - Indium photosensitizers for PDT (2002-09-03),

8. 6376483 - Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production (2002-04-23),

9. 6054449 - Compounds and method for PDT of intimal hyperplasia and other diseases (2000-04-25),

10. 5973141 - Method for the demethoxycarbonylation of porphyrinic compounds such as (1999-10-26),

Company Overview

Miravant Pharmaceuticals, Inc. is a biopharmaceutical company based in Santa Barbara, California, focused on developing innovative therapies for serious diseases. The company specializes in the field of photodynamic therapy, leveraging light-activated compounds to target and treat various medical conditions, particularly in oncology and ophthalmology. Miravant aims to enhance treatment efficacy while minimizing side effects, contributing to advancements in precision medicine and improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#51 in Santa Barbara, CA

#7,114 in California

#29,866 in US

#56,047 in the World

Santa Barbara, CA, United States of America

Miravant Pharmaceuticals, Inc.

Forward Citations = 206

11 inventors:

Byron C Robinson (10 out of 13 patents)

Avinash S Phadke (4 out of 4 patents)

Dipanjan Sengupta (3 out of 3 patents)

4. Barbara A Garcia (2 out of 2 patents)

5. G Patrick Stahly (1 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Miravant Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/miravant-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]